Cytocast
Budapest
About Cytocast
Cytocast is leveraging the integration of bioinformatics databases and patient data within a computer model to create a groundbreaking cell simulation software. This software holds the potential to revolutionize patient treatment, significantly impact the drug development process, and enable the identification of optimal therapeutic options. The comprehensive cell model that forms the basis of the technology combines molecular knowledge of how healthy cells function to understand the effects of perturbations caused by diseases and predict how drugs can modify cellular health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Pre-Seed (May 2023)
- Website: cytocast.com
- Phone: [email protected]
Industries & Categories
Bioinformatics, Biotechnology, Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cytocast-91463 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.